Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.5M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+5.89M
-
Total reported value, excl. options
-
$1.51B
-
Value change
-
+$271M
-
Put/Call ratio
-
0.17
-
Number of buys
-
97
-
Number of sells
-
-42
-
Price
-
$45.30
Significant Holders of Twist Bioscience Corp - Common Stock (TWST) as of Q2 2020
158 filings reported holding TWST - Twist Bioscience Corp - Common Stock as of Q2 2020.
Twist Bioscience Corp - Common Stock (TWST) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 60.5M outstanding shares and own 55.28% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (3.13M shares), BlackRock Inc. (2.87M shares), VANGUARD GROUP INC (1.66M shares), ARK Investment Management LLC (1.64M shares), STATE STREET CORP (1.6M shares), Tao Capital Management LP (1.32M shares), WELLINGTON MANAGEMENT GROUP LLP (1.25M shares), Casdin Capital, LLC (1M shares), Bank of New York Mellon Corp (980K shares), and Sumitomo Mitsui Trust Holdings, Inc. (977K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.